A comprehensive lot-to-lot variation assessment and comparative analysis of the Concerro CE-SDS kit against the Sciex CE-SDS kit for monoclonal antibody size variant analysis

Authors

  • Ravindra Bhavsar Pharmadesk Solutions Pvt. Ltd., Navi Mumbai, Maharashtra, India
  • Nikita Patel Department of Analytical Biopharma, Pharmadesk Solutions Pvt. Ltd., Navi Mumbai, Maharashtra, India
  • Rani Jaiswal Department of Analytical Biopharma, Pharmadesk Solutions Pvt. Ltd., Navi Mumbai, Maharashtra, India
  • Shailesh Agrahari Department of Analytical Biopharma, Pharmadesk Solutions Pvt. Ltd., Navi Mumbai, Maharashtra, India
  • Husain Thanawala Department of Analytical Biopharma, Pharmadesk Solutions Pvt. Ltd., Navi Mumbai, Maharashtra, India
  • Arati Patil Department of Analytical Biopharma, Pharmadesk Solutions Pvt. Ltd., Navi Mumbai, Maharashtra, India

DOI:

https://doi.org/10.18203/2320-6012.ijrms20260251

Keywords:

Monoclonal antibody, CE-SDS kit, Size variant analysis, Ipilimumab

Abstract

Background: Monoclonal antibodies (mAbs) are complex biotherapeutics whose quality and integrity must be stringently monitored throughout development and manufacturing. Capillary electrophoresis sodium dodecyl sulfate (CE-SDS) is the definitive analytical technique used globally for assessing size heterogeneity, including the presence of low molecular weight (LMW) fragments, high molecular weight (HMW) species, and ensuring accurate estimation of size of protein’s component. The objective of this study was to evaluate the analytical performance and manufacturing consistency of the newly introduced Concerro CE-SDS Kit against the established market innovator, the Sciex CE-SDS kit.

Methods: This study performed a head-to-head comparison utilizing the therapeutic monoclonal antibody Ipilimumab (Yervoi®). Analysis was conducted under both reduced and non-reduced conditions. Critical analytical performance indicators, including migration time, calculated peak area (mAu), calculated peak area percent (CPA%) were monitored during this study.

Results: The Concerro CE-SDS kit demonstrated analytical performance comparable to the Sciex CE-SDS kit, with similar precision and profile matching. Lot-to-lot variability for the Concerro CE-SDS kit showed %RSD values upto 10%.

Conclusions: The Concerro CE-SDS kit is affirmed as a robust, analytically equivalent alternative for high-precision size variant characterization in GxP/QC environments.

Metrics

Metrics Loading ...

Author Biographies

Nikita Patel, Department of Analytical Biopharma, Pharmadesk Solutions Pvt. Ltd., Navi Mumbai, Maharashtra, India

Manager at Pharmadesk Solutions Pvt. Ltd.

Rani Jaiswal, Department of Analytical Biopharma, Pharmadesk Solutions Pvt. Ltd., Navi Mumbai, Maharashtra, India

Assistant Manager at Pharmadesk Solutions Pvt. Ltd.

Shailesh Agrahari, Department of Analytical Biopharma, Pharmadesk Solutions Pvt. Ltd., Navi Mumbai, Maharashtra, India

Research Executive at Pharmadesk Solutions Pvt. Ltd.

Husain Thanawala, Department of Analytical Biopharma, Pharmadesk Solutions Pvt. Ltd., Navi Mumbai, Maharashtra, India

Research Associate at Pharmadesk solutions Pvt. Ltd.

Arati Patil, Department of Analytical Biopharma, Pharmadesk Solutions Pvt. Ltd., Navi Mumbai, Maharashtra, India

Trainee Research Associate at Pharmadesk Solutions Pvt. Ltd.

References

Cordoba-Rodriguez RV. Aggregates in MAbs and recombinant therapeutic proteins: a regulatory perspective. Bio Pharm Int. 2008;21:44-53.

Cordoba AJ, Shyong BJ, Breen D, Harris RJ. Nonenzymatic hinge region fragmentation of antibodies in solution. J Chromatogr B Analyt Technol Biomed Life Sci. 2005;818:115-21. DOI: https://doi.org/10.1016/j.jchromb.2004.12.033

Xiang T, Lundell E, Sun Z, Liu H. Structural effect of a recombinant monoclonal antibody on hinge region peptide bond hydrolysis. J Chromatogr B Analyt Technol Biomed Life Sci. 2007;858:254-62. DOI: https://doi.org/10.1016/j.jchromb.2007.08.043

Rosenberg AS. Effects of protein aggregates: an immunologic perspective. AAPSJ. 2006;8:E501-7. DOI: https://doi.org/10.1208/aapsj080359

Rosenberg AS, Worobec A. A risk-based approach to immunogenicity concerns of therapeutic protein products, part 2: considering host-specific and product specific factors impacting immunogenicity. Bio Pharm Int. 2004. Available at: http://www. biopharminternational.com/biopharm/21+CFR+Part+11/A-Risk-Based-Approach-to-Immunogenicity-Concerns-o/ArticleStandard/Article/detail/140695. Accessed on 04 November 2025.

Schenerman MA, Sunday BR, Kozlowski S, WebberK, Gazzano-Santoro H, Mire-Sluis A. CMC strategy forum report: analytical and structural characterization of monoclonal antibodies. Bio Process Int. 2004;2:42-52.

Rustandi RR, Washabaugh MW, Wang Y. Applications of CE SDS gel in development of biopharmaceutical antibody-based products. Electrophoresis. 2008;29:3612-20. DOI: https://doi.org/10.1002/elps.200700958

Zhang J, Burmana S, Gunturia S, Foley JP. Method development and validation of capillary sodium dodecyl sulfate gel electrophoresis for the characterization of a monoclonal antibody. J Pharm Biomed Analysis. 2010;53:1236-43. DOI: https://doi.org/10.1016/j.jpba.2010.07.029

Lacher NA, Roberts RK, He Y, Cargill H, Kearns KM, Holovics H, et al. Development, validation, and implementation of capillary gel electrophoresis as a replacement for SDSPAGE for purity analysis of IgG2 mAbs. J Sep Sci. 2010;33:1-10. DOI: https://doi.org/10.1002/jssc.200900597

SDS-MW Analysis Kit For the PA 800 Plus Pharmaceutical Analysis System Application Guide. Available at: https://sciex.jp/content/dam/SCIEX/pdf/ customer-docs/application-guide/pa-800-plus-system-sds-mw-analysis-kit-application-guide.pdf. 31-32. Accessed on 04 November 2025.

Agilent 7100 Capillary Electrophoresis System user manual. Available at: https://www.agilent.com/cs/ library/usermanuals/public/7100_CE_System_User_Manual.pdf?srsltid=AfmBOooU2fg5aKT0BYx_gNoyPiDhQfA7yBZzECkVETr8b86NxZa7fZZ-. Accessed on 04 November 2025.

Ensuring Lot-to-Lot Consistency in Protein Reagents: A Guide for Reproducible Research and Drug Development. 2025. Available at: https://www. proteinqc.com/posts/ensuring-lottolot-consistency-in-protein-reagents-a-guide-for-reproducible-research-and-drug development?utm_source=copilot. com. Accessed on 04 November 2025.

Thompson S, Chesher D. Lot-to-Lot Variation. Clin Biochem Rev. 2018;39(2):51-60.

Downloads

Published

2026-01-30

How to Cite

Bhavsar, R., Patel, N., Jaiswal, R., Agrahari, S., Thanawala, H., & Patil, A. (2026). A comprehensive lot-to-lot variation assessment and comparative analysis of the Concerro CE-SDS kit against the Sciex CE-SDS kit for monoclonal antibody size variant analysis. International Journal of Research in Medical Sciences, 14(2), 617–624. https://doi.org/10.18203/2320-6012.ijrms20260251

Issue

Section

Original Research Articles